2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$62.95-$0.09 (-0.14%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.2BMarket Cap
- -5.86%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$62.95-$0.09 (-0.14%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $63.04 | ||
Change | +$0.42 (+0.67%) | ||
Open | $62.62 | ||
High | $63.49 | ||
Low | $62.24 | ||
Previous Close | $62.62 | ||
Volume | 675,444 | ||
30-Day Average Volume | 1,119,562 | ||
1-Week Change | 3.36% | ||
1-Month Change | -4.43% | ||
1-Year Change | -5.63% | ||
3-Year Change | 171.61% | ||
5-Year Change | 75.16% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.3B | ||
Market Cap | $5.2B | ||
Enterprise Value | $4.8B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 29 | ||
Enterprise Value/Revenue | 20 | ||
P/B | -32 | ||
P/E | 68 | ||
PEG | 0 | ||
Price/Free Cash Flow | 41 | ||
Price/Operating Cash Flow | 40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue